Therefore, this systematic review and meta-analysis aimed to determine the pooled SMD of GFAP and NfL between COVID-19 patients and healthy controls and to generate evidence for the association between neurological injury-related biomarkers and the severity of COVID-19 infection. This evidence concerns the gene GFAP and COVID-19.